Quote | Amplitude Healthcare Acquisition Corporation (NASDAQ:AMHC)
Last: | $15.12 |
---|---|
Change Percent: | 5.29% |
Open: | $12.64 |
Close: | $15.12 |
High: | $15.8 |
Low: | $12.64 |
Volume: | 2,215,435 |
Last Trade Date Time: | 09/24/2021 04:56:20 pm |
News | Amplitude Healthcare Acquisition Corporation (NASDAQ:AMHC)
Combined company expected to begin trading on the Nasdaq Global Select Market under “JSPR” and “JSPRW” on or about September 27, 2021 Jasper Therapeutics, Inc., a biotechnology company focused on hematopoietic cell transplant therapies, today anno...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, investor! We’re diving back into the stock market again today with a look at the biggest pre-market stock movers for Thursday! Source: Shutterstock We’ve got loads of stock news to discus...
Message Board Posts | Amplitude Healthcare Acquisition Corporation (NASDAQ:AMHC)
Subject | By | Source | When |
---|---|---|---|
CRISPR CEO is board member of $AMHC | greenvestor2000 | investorshub | 09/23/2021 3:42:04 PM |
WOW CONGRAT$$$ | TheFinalCD | investorshub | 09/23/2021 12:28:40 PM |
How high can she go | INFINITI | investorshub | 09/23/2021 11:58:30 AM |
Yes. | dinogreeves | investorshub | 09/23/2021 3:05:59 AM |
https://ih.advfn.com/stock-market/NASDAQ/amplitude-healthcare-acq-$AMHC/stock-new | TheFinalCD | investorshub | 09/23/2021 2:59:20 AM |
News, Short Squeeze, Breakout and More Instantly...
Amplitude Healthcare Acquisition Corporation Company Name:
AMHC Stock Symbol:
NASDAQ Market:
Combined company expected to begin trading on the Nasdaq Global Select Market under “JSPR” and “JSPRW” on or about September 27, 2021 Jasper Therapeutics, Inc., a biotechnology company focused on hematopoietic cell transplant therapies, today anno...
Exhibit 99.1 REDWOOD CITY, Calif. and NEW YORK, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Amplitude Healthcare Acquisition Corporation (Nasdaq: AMHC) (“AMHC”), a special purpose acquisition company, today announced that its stockholders voted to approve the previously annou...